Thursday, November 12, 2026

Dollar Plunges to Three-Year Low as Euro Surges 14% in Global Currency Shift

The US dollar hit its weakest level since 2022, with the euro climbing 14% and the British pound gaining 7% in 2025. The currency realignment is reshaping forex markets worldwide, from European majors to emerging market pairs, as traders adjust to shifting central bank policies across continents.

ViaNews Editorial Team

February 21, 2026

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
Dollar Plunges to Three-Year Low as Euro Surges 14% in Global Currency Shift
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The US dollar fell to its lowest point since 2022, driving sharp gains across global currency markets. The euro rose 14% against the dollar in 2025, while the British pound climbed 7% over the same period.

The pound traded at $1.3086 in recent sessions, down 0.5% from earlier highs. Mizuho Bank's Jordan Rochester warns the currency could drop below $1.30 despite year-to-date gains. The euro reached €1.13 against the pound, its strongest level since April 2023.

The dollar's decline stems from changing Federal Reserve policy expectations and diverging economic growth rates between the US and Europe. European Central Bank interest rate decisions drive euro positioning, while Bank of England policy shapes pound movements. Swiss franc demand increased as investors sought safe-haven assets.

Currency volatility extends beyond developed markets. The Japanese yen swings on monetary policy signals from the Bank of Japan, while Middle Eastern pairs react to Iran nuclear negotiations. Emerging market currencies face increased pressure as dollar weakness reshuffles global capital flows.

Technical levels matter for traders worldwide. The pound's $1.30 threshold represents key support that could trigger stop-loss orders. The euro's rally creates potential resistance near recent peaks, complicating position sizing for forex desks from London to Singapore.

Options markets price in sustained volatility. Implied volatility on major dollar pairs remains elevated compared to 2023-2024 levels, raising hedging costs for multinational corporations and institutional investors.

Historical forex cycles typically run 18-36 months. Current dollar weakness entered month eight, suggesting either extended trends or sharp reversals depending on upcoming economic data from major economies.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  3. [3]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com